netFormulary
 Report : A-Z HCD items in Formulary 13/06/2021 13:04:49
[Back]
 
Section Status BlueTeq Name
01.05.03 Formulary BlueTeq Adalimumab 
11.08.02 Formulary BlueTeq Aflibercept Eylea®
02.12 Formulary BlueTeq Alirocumab Praluent®
13.05.02 Formulary BlueTeq Apremilast Otezla®
09.01.04 Formulary BlueTeq Avatrombopag Doptelet®
13.05.03 Formulary BlueTeq Baricitinib Olumiant®
04.12 Formulary BlueTeq Botulinum neurotoxin Type A Xeomin®
04.07.04.02 Formulary BlueTeq Botulinum Toxin Type A Botox®
11.08.02 Formulary BlueTeq Brolucizumab Beovu®
09.01.04 Formulary BlueTeq Eltrombopag  Revolade®
04.07.04.02 Formulary BlueTeq Erenumab Aimovig®
02.12 Formulary BlueTeq Evolocumab Repatha®
10.01.03 Formulary BlueTeq Filgotinib Jyseleca®
06.01.06 Formulary BlueTeq Flash glucose monitoring system FreeStyle Libre® FreeStyle Libre 2®
04.07.04.02 Formulary BlueTeq Fremanezumab Ajovy®
04.07.04.02 Formulary BlueTeq Galcanezumab Emgality®
01.05.03 Formulary BlueTeq Golimumab Simponi®
01.05.03 Formulary BlueTeq Infliximab 
09.01.04 Formulary BlueTeq Lusutrombopag Mulpleo®
03.04.02 Restricted Use BlueTeq Omalizumab 
11.08.02 Formulary BlueTeq Ranibizumab Lucentis®
13.05.03 Formulary BlueTeq Risankizumab Skyrizi®
09.01.04 Formulary BlueTeq Romiplostim Nplate®
01.05.03 Formulary BlueTeq Tofacitinib Xeljanz®
10.01.03 Formulary BlueTeq Tofacitinib  Xeljanz ®
10.01.03 Formulary BlueTeq Upadacitinib Rinvoq®
01.05.03 Formulary BlueTeq Ustekinumab Stelara®
13.05.03 Formulary BlueTeq Ustekinumab 
01.05.03 Formulary BlueTeq Vedolizumab Entyvio®
South Staffordshire Joint Formulary